Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.
about
A Unique and Conserved Neutralization Epitope in H5N1 Influenza Viruses Identified by an Antibody against the A/Goose/Guangdong/1/96 HemagglutininNanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infectionH5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer modelRise and fall of an anti-MUC1 specific antibodyRapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases.Neuraminidase and hemagglutinin matching patterns of a highly pathogenic avian and two pandemic H1N1 influenza A viruses.Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice.Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in miceA human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.Passive immune neutralization strategies for prevention and control of influenza A infections.Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin.Novel reassortant highly pathogenic H5N2 avian influenza viruses in poultry in China.Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodiesDesign and utilization of epitope-based databases and predictive toolsBeyond natural antibodies: the power of in vitro display technologies.Comprehensive analysis of pathogen-specific antibody response in vivo based on an antigen library displayed on surface of yeastDetermining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses.The epitope and neutralization mechanism of AVFluIgG01, a broad-reactive human monoclonal antibody against H5N1 influenza virus.Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein.Antigenic Variation in H5N1 clade 2.1 Viruses in Indonesia From 2005 to 2011.Properties and therapeutic efficacy of broadly reactive chimeric and humanized H5-specific monoclonal antibodies against H5N1 influenza virusesA high-affinity CDR-grafted antibody against influenza A H5N1 viruses recognizes a conserved epitope of H5 hemagglutinin.Potent and broad anti-HIV-1 activity exhibited by a glycosyl-phosphatidylinositol-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16.Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody.Lepidopteran cells, an alternative for the production of recombinant antibodies?Translational research in infectious disease: current paradigms and challenges ahead.Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.Selection of Recombinant Human Antibodies.Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy.Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infectionTrimeric glycosylphosphatidylinositol-anchored HCDR3 of broadly neutralizing antibody PG16 is a potent HIV-1 entry inhibitorUnraveling of a neutralization mechanism by two human antibodies against conserved epitopes in the globular head of H5 hemagglutinin.A human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect.Cross-protection of newly emerging HPAI H5 viruses by neutralizing human monoclonal antibodies: A viable alternative to oseltamivir.Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses.Prospects of HA-based universal influenza vaccine.Antibody Phage DisplayComplementary recognition of the receptor-binding site of highly pathogenic H5N1 influenza viruses by two human neutralizing antibodiesIsolation and Characterization of Human Monoclonal Antibodies That Recognize the Influenza A(H1N1)pdm09 Virus Hemagglutinin Receptor-Binding Site and Rarely Yield Escape Mutant Viruses
P2860
Q27679987-2B09B45C-05D4-41DC-942A-538EBC46E098Q28308105-06A857D6-B1FB-4481-B111-71798C3DF453Q28741304-69B5D548-C22A-47E8-B174-508EE0EEF675Q28743508-5BBDFE70-BE7F-4013-A4FF-3CCC29621C45Q30222441-F332A672-45D2-4869-ADAC-95B8AB5C00B6Q30385742-CA6685E4-8470-4AD1-AC18-BBFB316C1B03Q30388253-BA22B647-B243-4902-8308-F492044E05FCQ30391974-3266584D-FA96-4F57-BCB5-7714392F5457Q30411637-1279F62C-5855-4803-B9A7-AFD555D6AA9EQ30413158-BC7AD300-5414-4659-8B78-609592454EE6Q30535722-CDD4D17A-3A4A-4539-B290-47FF02CAE6DFQ31104428-825FDF3F-CA80-44F1-AA4A-94F082E502E4Q33401906-FFE09D7A-7171-47EB-B419-AE92010B9419Q33746654-052EA184-4441-4070-9536-05B8EDC407D2Q33841864-E867844B-D189-4296-9AFD-0EB3E464CD9EQ33973410-BCA8B9A5-382B-4864-961C-446DADB8C7A9Q34057878-8E2EF166-EF80-402F-BEBB-85082C451420Q34291530-CD8D13B4-52B7-46E4-A13D-8B56912AF96BQ34296691-AC13221D-519C-424B-9F15-DC98BA525757Q34463090-C343534C-02A7-406A-9C85-C298CA88604EQ34737817-151EA365-5447-4063-8E4A-A5481BD0A56FQ35099676-6A11EBB3-3538-4A21-930D-DA59074F4FD2Q35192886-730D958A-DD75-47CA-9264-14DB7ABFAAA9Q35909991-81CE0C49-16C1-4E49-8C50-FEBC6196F151Q35969904-78B561C9-8EB8-4D2F-8BB1-A2F950FE7B9FQ35992621-66CAC35F-30E0-4643-8A68-80D7383B34F1Q36023082-C9C03691-08F1-4E24-A7C9-5A241A51573AQ36033281-E84FC142-D933-45D5-8323-2FF8D4BB0E25Q36033286-5C2A2F9D-B081-4095-8AA9-F200C4D33CE7Q36392511-19AF5D40-0497-429F-AAD3-80B30E6F7B10Q36559942-E2EFE2AE-5D1F-48B7-95A6-240A15C49215Q36667857-F6944C2A-929F-40C1-80C0-8303FED03BE1Q37138946-4563D056-CE11-4823-A837-23A43176D61AQ37141589-B9328428-C545-411D-931D-071EB2C0F4E6Q39625153-D68715FF-F308-4909-951E-1FAC1A642C35Q41416400-70D13287-A35A-422B-B4E6-02EAF534447BQ58007992-8DACEBCC-CCF6-4C6D-AF72-4F6598021032Q58696897-86FC9087-50E8-4F75-83D4-8961A9AD1C23Q59132925-E29E0A7E-98A2-4146-BD9A-CD76FDC147DB
P2860
Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Generation, characterization a ...... inst influenza A H5N1 viruses.
@ast
Generation, characterization a ...... inst influenza A H5N1 viruses.
@en
type
label
Generation, characterization a ...... inst influenza A H5N1 viruses.
@ast
Generation, characterization a ...... inst influenza A H5N1 viruses.
@en
prefLabel
Generation, characterization a ...... inst influenza A H5N1 viruses.
@ast
Generation, characterization a ...... inst influenza A H5N1 viruses.
@en
P2093
P2860
P50
P1433
P1476
Generation, characterization a ...... inst influenza A H5N1 viruses.
@en
P2093
Jiandong Li
Kathy Hancock
Mifang Liang
Qinzhi Liu
Xiaofen Hu
P2860
P356
10.1371/JOURNAL.PONE.0005476
P407
P577
2009-05-07T00:00:00Z